ArticleBioPsychoSocial medicine2020
Effect of relaxation therapy on benzodiazepine use in patients with medically unexplained symptoms.
Article in BioPsychoSocial medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- Psychometric Evaluation of Indonesian Version of the Somatic Symptom Scale-8 (ISSS-8).Journal of caring sciences · 2025Review
- Determining the Minimal Clinically Important Difference in Somatic Symptom Scale-8 Score in Patients With Somatic Symptoms and Related Disorders: A Six-Month Follow-Up Study.Alpha psychiatry · 2025Article
- Psychosomatic symptoms related to exacerbation of fatigue in patients with medically unexplained symptoms.Journal of general and family medicine · 2023Article
- Utility and optimal cut-off point of the Somatic Symptom Scale-8 for central sensitization syndrome among outpatients with somatic symptoms and related disorders.BioPsychoSocial medicine · 2022Article
- Effect of central sensitization on dizziness-related symptoms of persistent postural-perceptual dizziness.BioPsychoSocial medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe change in the benzodiazepine (BZD) use of patients with medically unexplained symptoms (MUS) following the application of relaxation therapy were examined.
methodsOf the 221 outpatients with MUS using BZD, 42 received relaxation therapy. Change in BZD use was compared using a relaxation group (
resultsCompared with the control group, the number of patients who decreased the amount of BZD and the number of patients whose subjective symptoms of MUS improved were significantly higher in the relaxation group (
conclusionsRelaxation therapy for patients with MUS may help reduce BZD use; however, early intervention is important to prevent BZD dependence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.